Αποτελέσματα Αναζήτησης
4 Ιαν 2023 · Sunlenca is the first of a new class of drugs called capsid inhibitors to be FDA-approved for treating HIV-1. Sunlenca works by blocking the HIV-1 virus’ protein shell (the capsid), thereby interfering with multiple essential steps of the viral lifecycle.
- FDA Approves First Extended-Release, Injectable Drug Regimen for Adults ...
[Yesterday] the U.S. Food and Drug Administration approved...
- FDA Approves First Extended-Release, Injectable Drug Regimen for Adults ...
22 Ιαν 2021 · [Yesterday] the U.S. Food and Drug Administration approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral ...
23 Δεκ 2021 · Apretude, a new drug approved by the FDA this week, is an injection that has proven to be significantly more effective at reducing the risk of sexually-acquired HIV.
27 Ιαν 2021 · This is the first FDA-approved injectable, complete regimen for HIV-1 infected adults that is administered once a month.
22 Αυγ 2023 · Aug. 22, 2023. An influential expert panel has given its highest recommendation to an expanded menu of H.I.V. prevention strategies for adults and adolescents, a move that will require...
21 Ιαν 2021 · Today, the FDA approved Cabenuva as the first injectable, complete regimen for HIV-infected adults that is administered once a month.
25 Νοε 2008 · SELZENTRY is part of a new class of drugs called CCR5 antagonists, providing a new approach to HIV treatment. A diagnostic test confirms whether a patient is infected with CCR5-tropic HIV-1, which is also known as “R5 virus”.
